These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 21381290

  • 1. [Pegfilgrastim in hematopoietic stem cell transplantation].
    Fernández Alvarez R.
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():57-61. PubMed ID: 21381290
    [Abstract] [Full Text] [Related]

  • 2. The role of pegfilgrastim in mobilization of hematopoietic stem cells.
    Kroschinsky F, Hölig K, Ehninger G.
    Transfus Apher Sci; 2008 Jun; 38(3):237-44. PubMed ID: 18490197
    [Abstract] [Full Text] [Related]

  • 3. A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy.
    Bassi S, Rabascio C, Nassi L, Steffanoni S, Babic A, Bertazzoni P, Gigli F, Antoniotti P, Orlando L, Sammassimo S, Quarna J, Negri M, Martinelli G.
    Transfus Apher Sci; 2010 Dec; 43(3):321-326. PubMed ID: 21036667
    [Abstract] [Full Text] [Related]

  • 4. Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT.
    Kobbe G, Bruns I, Fenk R, Czibere A, Haas R.
    Bone Marrow Transplant; 2009 May; 43(9):669-77. PubMed ID: 19308043
    [Abstract] [Full Text] [Related]

  • 5. A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma.
    Bruns I, Steidl U, Kronenwett R, Fenk R, Graef T, Rohr UP, Neumann F, Fischer J, Scheid C, Hübel K, Haas R, Kobbe G.
    Transfusion; 2006 Feb; 46(2):180-5. PubMed ID: 16441592
    [Abstract] [Full Text] [Related]

  • 6. Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cells.
    Herbert KE, Gambell P, Link EK, Mouminoglu A, Wall DM, Harrison SJ, Ritchie DS, Seymour JF, Prince HM.
    Bone Marrow Transplant; 2013 Mar; 48(3):351-6. PubMed ID: 22858510
    [Abstract] [Full Text] [Related]

  • 7. [Hematopoietic growth factors and autologous or allogeneic stem cell transplantation].
    Bay JO, Peffault de Latour R, Tournilhac O, Choufi B, Chassagne J.
    Bull Cancer; 2006 May; 93(5):473-82. PubMed ID: 16777625
    [Abstract] [Full Text] [Related]

  • 8. Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.
    Perrier L, Lefranc A, Pérol D, Quittet P, Schmidt-Tanguy A, Siani C, de Peretti C, Favier B, Biron P, Moreau P, Bay JO, Lissandre S, Jardin F, Espinouse D, Sebban C.
    Appl Health Econ Health Policy; 2013 Apr; 11(2):129-38. PubMed ID: 23435861
    [Abstract] [Full Text] [Related]

  • 9. Long-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilization.
    Martino M, Laszlo D, Lanza F.
    Expert Opin Biol Ther; 2014 Jun; 14(6):757-72. PubMed ID: 24597960
    [Abstract] [Full Text] [Related]

  • 10. A randomized double blind control trial comparing filgrastim and pegfilgrastim in cyclophosphamide peripheral blood hematopoietic stem cell mobilization.
    Kuan JW, Su AT, Wong SP, Sim XY, Toh SG, Ong TC, Rajasuriarr JS, Lim SH, Guan YK, Liew HK, Liew PK, Tan JT, Kori AN, Cheng YY, Tan SM, Chang KM.
    Transfus Apher Sci; 2015 Oct; 53(2):196-204. PubMed ID: 25910537
    [Abstract] [Full Text] [Related]

  • 11. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.
    Sivgin S, Karakus E, Kaynar L, Kurnaz F, Pala C, Keklik M, Zararsiz G, Solmaz M, Eser B, Cetin M, Unal A.
    Transfus Apher Sci; 2013 Jun; 48(3):315-20. PubMed ID: 23611684
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of single-dose 6 mg pegfilgrastim in mobilizing peripheral blood stem cells in allogeneic hematopoietic cell transplantation donors.
    Cao J, Li A, Pei R, Lu Y, Chen D, Du X, Liu X, Li S, Ye P.
    Ann Hematol; 2023 Dec; 102(12):3567-3573. PubMed ID: 37773294
    [Abstract] [Full Text] [Related]

  • 13. Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma.
    Rifkin R, Spitzer G, Orloff G, Mandanas R, McGaughey D, Zhan F, Boehm KA, Asmar L, Beveridge R.
    Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):186-91. PubMed ID: 20511163
    [Abstract] [Full Text] [Related]

  • 14. Feasibility and kinetics of CD34+ hematopoietic progenitor cell mobilization in response to a single administration of docetaxel chemotherapy and pegfilgrastim in a contemporary cohort of patients with metastatic breast cancer.
    Takhar H, Mislang AR, Singhal N, Brown MP.
    Asia Pac J Clin Oncol; 2017 Feb; 13(1):79-86. PubMed ID: 27649817
    [Abstract] [Full Text] [Related]

  • 15. Spotlight on pegfilgrastim in chemotherapy-induced neutropenia.
    Frampton JE, Keating GM.
    BioDrugs; 2005 Feb; 19(6):405-7. PubMed ID: 16392893
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pegfilgrastim.
    Willis F, Pettengell R.
    Expert Opin Biol Ther; 2002 Dec; 2(8):985-92. PubMed ID: 12517276
    [Abstract] [Full Text] [Related]

  • 18. Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma.
    Steidl U, Fenk R, Bruns I, Neumann F, Kondakci M, Hoyer B, Gräf T, Rohr UP, Bork S, Kronenwett R, Haas R, Kobbe G.
    Bone Marrow Transplant; 2005 Jan; 35(1):33-6. PubMed ID: 15531906
    [Abstract] [Full Text] [Related]

  • 19. Pegfilgrastim: current and future perspectives in the treatment of chemotherapy-induced neutropenia.
    Ricotta R, Cerea G, Schiavetto I, Maugeri MR, Pedrazzoli P, Siena S.
    Future Oncol; 2006 Dec; 2(6):667-76. PubMed ID: 17155894
    [Abstract] [Full Text] [Related]

  • 20. Pegylated Filgrastim Versus Filgrastim for Stem Cell Mobilization in Multiple Myeloma After Novel Agent Induction.
    Abid MB, De Mel S, Abid MA, Yap ES, Gopalakrishnan SK, Chen Y, Yuen YC, Wong HC, Lin A, Poon LM, Koh LP, Chng WJ, Tan LK.
    Clin Lymphoma Myeloma Leuk; 2018 Mar; 18(3):174-179. PubMed ID: 29398647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.